Severance Hospital Yonsei University Health System — Seoul

Public research footprint of Severance Hospital Yonsei University Health System, compiled from the ClinicalTrials.gov public registry.

1,057

Registered studies

480

Active

250

Recruiting now

423

Completed

112

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Non-small Cell Lung Cancer · Triple Negative Breast Neoplasms · Primary Biliary Cholangitis (PBC)

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Severance Hospital Yonsei University Health System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.